1. Home
  2. PRPO vs UPC Comparison

PRPO vs UPC Comparison

Compare PRPO & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • UPC
  • Stock Information
  • Founded
  • PRPO N/A
  • UPC 1998
  • Country
  • PRPO United States
  • UPC China
  • Employees
  • PRPO 57
  • UPC N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • UPC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPO Industrials
  • UPC Health Care
  • Exchange
  • PRPO Nasdaq
  • UPC Nasdaq
  • Market Cap
  • PRPO 9.5M
  • UPC 6.2M
  • IPO Year
  • PRPO N/A
  • UPC 2021
  • Fundamental
  • Price
  • PRPO $6.59
  • UPC $0.36
  • Analyst Decision
  • PRPO
  • UPC
  • Analyst Count
  • PRPO 0
  • UPC 0
  • Target Price
  • PRPO N/A
  • UPC N/A
  • AVG Volume (30 Days)
  • PRPO 7.9K
  • UPC 4.3M
  • Earning Date
  • PRPO 11-11-2024
  • UPC 01-01-0001
  • Dividend Yield
  • PRPO N/A
  • UPC N/A
  • EPS Growth
  • PRPO N/A
  • UPC N/A
  • EPS
  • PRPO N/A
  • UPC N/A
  • Revenue
  • PRPO $16,719,999.00
  • UPC $26,725,919.00
  • Revenue This Year
  • PRPO $75.18
  • UPC N/A
  • Revenue Next Year
  • PRPO N/A
  • UPC N/A
  • P/E Ratio
  • PRPO N/A
  • UPC N/A
  • Revenue Growth
  • PRPO 52.61
  • UPC N/A
  • 52 Week Low
  • PRPO $4.31
  • UPC $0.20
  • 52 Week High
  • PRPO $8.99
  • UPC $4.32
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 52.82
  • UPC 30.58
  • Support Level
  • PRPO $6.42
  • UPC $0.31
  • Resistance Level
  • PRPO $6.99
  • UPC $1.00
  • Average True Range (ATR)
  • PRPO 0.33
  • UPC 0.09
  • MACD
  • PRPO -0.04
  • UPC 0.12
  • Stochastic Oscillator
  • PRPO 69.91
  • UPC 20.17

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Share on Social Networks: